Abstract
Pancreatic adenocarcinoma contributes to high mortality among solid malignancies, which is usually detected at an advanced stage of metastasis. Terpenoids are the major class of naturally occurring biologically active compounds and can be explored for the drug discovery with the anticancer property. The approach has to be made in identifying a variety of terpenoids against metastatic cancer. This chapter is aimed to discuss the current advances in pancreatic adenocarcinoma, including specific target of terpenoids that are associated with NF-κB signaling, caspases, DNA damage, and apoptotic proteins.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
